FTC warns consumers about bogus cancer cures

September 18, 2008 By RANDOLPH E. SCHMID , AP Science Writer

(AP) -- The Federal Trade Commission charged five companies with making false and misleading claims for cancer cures and said Thursday that it has reached settlements with six others. "As long as products have been sold there has been somebody out there selling snake oil to consumers," said Lydia Parnes, director of the FTC's bureau of consumer protection.

Content from The Associated Press expires 15 days after original publication date. For more information about The Associated Press, please visit www.ap.org .

Similar stories from PHYSorg:

Companies pledge more openness about Web tracking

Jul 02, 2009 | 1 / 5 (1) | 1

FTC: Bloggers, testimonials need better disclosure (Update 2)

Oct 05, 2009 | not rated yet | 3

NY official: Tagged site stole identities

Jul 09, 2009 | 5 / 5 (2) | 0

Gov't addresses 'robocall' annoyance with new ban

Aug 27, 2009 | 5 / 5 (1) | 0

GAO: FCC must improve wireless industry oversight

Dec 10, 2009 | not rated yet | 0

Rate this story - 5 /5 (1 vote)

rank
1
2
3
4
5

view popular

Other News

Blueberries counteract intestinal diseases

Medicine & Health / Health

30 minutes ago | not rated yet | 0

It is already known that blueberries are rich in antioxidants and vitamins. New research from the Lund University Faculty of Engineering in Sweden shows that blueberry fibre are important and can alleviate and protect against ...

Research identifies gene with likely role in premenstrual disorder

Medicine & Health / Genetics

39 minutes ago | not rated yet | 0

Scientists have identified a gene they say is a strong candidate for involvement in premenstrual dysphoric disorder (PMDD) and other maladies associated with the natural flux in hormones during the menstrual cycle. In a paper ...

Low forms of cyclin E reduce breast cancer drug's effectiveness

Medicine & Health / Cancer

10 minutes ago | not rated yet | 0

Overexpression of low-molecular-weight (LMW-E) forms of the protein cyclin E renders the aromatase inhibitor letrozole ineffective among women with estrogen-receptor-positive (ER+) breast cancers, researchers from The University ...

Racial disparities persist in the diagnosis of advanced breast cancer and colon cancer in the U.S.

Medicine & Health / Cancer

50 minutes ago | not rated yet | 0

The incidence of advanced breast cancer diagnosis among black women remained 30 percent to 90 percent higher compared to white women between 1992 and 2004, according to new findings by researchers at Fred Hutchinson Cancer ...